🔬 The mixer is designed to address challenges faced by customers in large-scale manufacturing processes.
🌐 It comes in 2000 and 3000 L capacities, with flexible configurations to cater to diverse mixing processes.
💧 The mixer’s design prevents leaks, reducing time and money losses.
🌀 The impeller and hexagonal shape of the mixer create a vortex that improves the mixing process.
💼 The compact size of the mixer allows it to fit into tight facility spaces without compromising capacity.
🚀 Cytiva aims to quickly get life-changing therapies to patients by addressing customer challenges.
Introduction:
Cytiva has unveiled its new Xcellerex magnetic mixer at the Interphex meeting in New York. The mixer is designed to address challenges faced by customers involved in large-scale monoclonal antibody, vaccine, and genomic medicine manufacturing processes. It is available in 2000 and 3000 L capacities and offers various configurations for different mixing processes.
- The Xcellerex magnetic mixer aims to solve challenges faced by customers in large-scale manufacturing processes.
- The mixer incorporates user-centered design elements to enhance durability and prevent leaks.
- The mixer’s impeller and hexagonal shape create a vortex that improves mixing efficiency and reduces mixing time.
- The compact size of the mixer allows it to fit into tight facility spaces without compromising capacity.
- Cytiva aims to provide solutions for process engineers and scientists to accelerate the production of life-changing therapies.
Conclusion:
Cytiva’s Xcellerex magnetic mixer offers a solution to challenges faced in large-scale manufacturing processes. With its enhanced durability, leak prevention features, and efficient mixing capabilities, the mixer has the potential to improve productivity and reduce downtime. Its compact size also makes it suitable for facilities with limited space. The introduction of this mixer demonstrates Cytiva’s commitment to providing innovative solutions in bioprocessing to accelerate the development of life-saving therapies.
